Clinical trial
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
NCT00036517 is registered in ClinicalTrials.gov with PhytoCeutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
- Lead sponsor
- PhytoCeutica
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- February 28, 2002
- Completion date
- March 31, 2003
- Enrollment
- 30
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.